Advanced Multiomic Platforms Will Redefine Global Healthcare Standards
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
07 Aug 25
Updated
16 Aug 25
AnalystHighTarget's Fair Value
US$2.25
45.3% undervalued intrinsic discount16 Aug
US$1.23
1Y
-30.5%7D
-5.7%